Overview and update of the phase III Multicenter Selective Lymphadenectomy Trials (MSLT-I and MSLT-II) in melanoma

Overview and update of the phase III Multicenter Selective Lymphadenectomy Trials (MSLT-I and MSLT-II) in melanoma

This short review offers an update on the first and second Multicenter Selective Lymphadenectomy Trials (MSLT-I and MSLT-II) for patients with melanoma, and briefly traces the development of intraoperative lymphatic mapping and sentinel node biopsy.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical & experimental metastasis 2012-10, Vol.29 (7), p.699-706
1. Verfasser: Morton, Donald L.
Format: Artikel
Sprache:eng
Schlagworte:
Biomedical and Life Sciences
Biomedicine
Cancer Research
Hematology
Humans
Lymph Node Excision
Lymphatic Metastasis - diagnosis
Melanoma - pathology
Melanoma - surgery
Oncology
Quality of Life
Research Paper
Sentinel Lymph Node Biopsy
Skin Neoplasms - pathology
Skin Neoplasms - surgery
Surgical Oncology
Survival
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:This short review offers an update on the first and second Multicenter Selective Lymphadenectomy Trials (MSLT-I and MSLT-II) for patients with melanoma, and briefly traces the development of intraoperative lymphatic mapping and sentinel node biopsy.
ISSN:0262-0898
1573-7276
DOI:10.1007/s10585-012-9503-3